Today pharmaceutical and biotechnology industry is undergoing a fundamental transformation in its approach to drug research and development, moving away from pursuing block buster drugs to target therapies. With an increased focus of companies on innovative and targeted therapies, characterization of disease conditions at a granular level is becoming an essential component for global pharmaceutical and biotechnology companies for developing winning strategies and successful drug commercialization.

gepis is a specialized service provider of epidemiology solutions to world's pharmaceutical, and biotechnology companies. gepis offers customized high quality and cost-effective EPI solutions and products to global clients by delivering evidence based epidemiology data and insights through our in-depth knowledge of global and local data sources, scientific analytics and technology adoption.